| Literature DB >> 31341177 |
Rafael Nacif-Pimenta1,2, Alessandra da Silva Orfanó3, Ilana A Mosley1, Shannon E Karinshak1, Kenji Ishida4, Victoria H Mann1, Paulo Marcos Zech Coelho2, José M Correia da Costa5,6, Michael H Hsieh4,7,8, Paul J Brindley9, Gabriel Rinaldi10,11.
Abstract
Chronic urogenital schistosomiasis can lead to squamous cell carcinoma of the bladder. The International Agency for Research on Cancer classifies the infection with S. haematobium as a group 1 carcinogen, a definitive cause of cancer. By contrast, hepatointestinal schistosomiasis due to the chronic infection with S. mansoni or S. japonicum associated with liver periportal fibrosis, does not apparently lead to malignancy. The effects of culturing human epithelial cells, HCV29, established from normal urothelium, and H69, established from cholangiocytes, in the presence of S. haematobium or S. mansoni eggs were investigated. Cell growth of cells co-cultured with schistosome eggs was monitored in real time, and gene expression analysis of oncogenesis, epithelial to mesenchymal transition and apoptosis pathways was undertaken. Schistosome eggs promoted proliferation of the urothelial cells but inhibited growth of cholangiocytes. In addition, the tumor suppressor P53 pathway was significantly downregulated when exposed to schistosome eggs, and downregulation of estrogen receptor was predicted in urothelial cells exposed only to S. haematobium eggs. Overall, cell proliferative responses were influenced by both the tissue origin of the epithelial cells and the schistosome species.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31341177 PMCID: PMC6656753 DOI: 10.1038/s41598-019-46917-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Proliferation of urothelial cells and cholangiocytes in response to schistosome eggs, monitored in real time using the xCELLigence system. Non-contact co-culture of Schistosoma mansoni and S. haematobium eggs with HCV29 cells (Panel A) or H69 cells (Panel B) over time after the addition of the eggs. Cell growth is expressed as percentage of the Normalized Cell Index of cells co-cultured with eggs compared with control cells (control cell growth rate = 100%). All curves represent the averages of at least three technical replicates for the experiment and standard deviations are shown as error bars at each data point. Blue and red asterisks indicate levels of significance (P ≤ 0.01) of growth ratios of cells cultured with S. mansoni and S. haematobium eggs, compared to control cells cultured in the absence of eggs, respectively. Sm live: S. mansoni live eggs; Sm heat-killed: heat-killed S. mansoni eggs; Sh live: S. haematobium live eggs; Sh heat-killed: heat-killed S. haematobium eggs.
Figure 2Schistosome eggs induced dysregulation of oncogenes, tumor suppressors and EMT-related genes in HCV29 cells over time. Volcano plots of HCV29 cell gene response to non-contact co-culture with S. mansoni or S. haematobium eggs as indicated, for 2 (Panel A) or 24 (Panel B) hours. Gene expression was measured using qPCR gene arrays designed to assess oncogenesis- and EMT- associated transcripts. Significantly dysregulated (P < 0.05) genes with >±1.5-fold-change, are shown. Panel C. Venn diagram compiled only with the HCV29 cell culture conditions that share differentially expressed genes (DEG) – only upregulated genes were shared among the 3 indicated conditions. (Table S2 includes the complete set of DEG indicated in the Venn diagram).
Figure 3Schistosome eggs induced dysregulation of apoptosis-related genes in H69 cells. Volcano plot of the H69 cell gene response to non-contact co-culture with S. mansoni or S. haematobium eggs as indicated for 24 hours. Gene expression was measured using qPCR gene arrays designed to assess apoptosis-associated transcripts. Significantly dysregulated (P < 0.05) genes with >±1.5-fold-change, are shown. (Table S1 includes the complete data set of gene expression changes.) Panel B. Venn diagram compiled only with the H69 cell culture conditions that share differentially expressed genes (DEG) – only downregulated genes were shared between the two conditions indicated.
Figure 4Significant dysregulation of genes involved in Colorectal Cancer Signaling Pathway in urothelial cells. The pathway was significantly dysregulated at early time point in S. mansoni eggs co-cultured HCV29 cells, and all the perturbed genes were upregulated (genes colored in red). Adapted from map05210 Colorectal cancer, KEEG Database[63–65].
Differentially expressed genes associated with Colorectal Cancer Signaling Pathway identified in HCV29 cells exposed to eggs of Schistosoma haematobium (Sh) or S. mansoni (Sm).
| Gene name (ID) | HCV29 cell line* | Gene description | Reference | |
|---|---|---|---|---|
TNF (Tumor Necrosis Factor) | NS | ↑ 9.72 ( | Pro-inflammatory cytokine implicated in colorectal cancers, associated with tumor growth, proliferation and metastasis |
[ |
RUNX1 (Runt Related Transcription Factor 1) | NS | ↑ 4.59 ( | Transcription factor with tumor suppressor functions associated with growth promotion of skin, oral, breast and ovarian tumor cells. |
[ |
MYC (Proto-Oncogene) | NS | ↑ 4.01 ( | Transcription factor involved in cell proliferation, inhibition of cell differentiation and apoptosis. Over expressed in over 50% of all cancers, is considered a metastasis marker. |
[ |
JUN (Proto-Oncogene, AP-1 Transcription Factor Subunit) | NS | ↑ 3.34 ( | Transcription factor involves in cell cycle progression, cell survival, transformation and proliferation. Over expression of JUN has been related to p53 repression. |
[ |
NFKB1 (Nuclear Factor Kappa B subunit 1) | NS | ↑ 2.82 ( | Transcription factor responsible for the regulation of ~300 genes involved with immune, growth and inflammation processes. Over expressed in many cancer types including colorectal, breast, liver, prostate and kidney. |
[ |
SRC (Proto-Oncogene, Non-Receptor Tyrosine Kinase) | NS | ↑ 2.72 ( | Proto-oncogene over expressed in colorectal, pancreas and prostate cancer, implicated in tumor progression, cell migration, angiogenesis, and metastasis. |
[ |
BCL2 (Apoptosis regulator) | NS | ↑ 2.69 ( | Anti-apoptotic regulator involved in several lymphomas. When over expressed, it has been associated with low survival of diffuse large B-cell lymphoma |
[ |
*Fold change and P value, upregulation (↑), downregulation (↓), NS: non-significant. The exposure time of cells co-cultured with indicated schistosome eggs (2 h and/or 24 h) for which the specific gene expression dysregulation was detected is indicated after the Fold change.
Figure 5Significant dysregulation of P53 pathway in urothelial cells exposed to either S. haematobium or S. mansoni eggs for 24 hours. P53 pathway highlighting upregulated or downregulated genes in red or green, respectively. Genes affected by S. mansoni or S. haematobium are indicated by blue or red squares, respectively. Adapted from map04115 p53 signaling pathway, KEEG Database[63–65].
Differentially expressed genes associated with P53 Signaling Pathway identified in HCV29 cells exposed to either eggs of Schistosoma haematobium (Sh) or S. mansoni (Sm).
| Gene name (ID) | HCV29 cell line* | Gene description | Reference | |
|---|---|---|---|---|
SERPINB5 (Serpin Family B, member 5) | NS | ↓ −3.09 ( | Inhibitor of cancer cell invasion, metastasis and angiogenesis. Under expression associated with breast, prostate, thyroid and skin tumors. |
[ |
ATM (Ataxia Telangiectasia Mutated, Serine/Threonine kinase) | ↓ −2.69 (p = 0.043) 24 h | NS | Mediator in kinase cascade that controls DNA damage response, cell-cycle progression, DNA recombination and apoptosis. Its downregulation inhibits p53 and cell cycle arrest. |
[ |
MDM2 (MDM2 Proto-Oncogene) | ↓ −2.64 ( | NS | Ubiquitin E3 ligase that degrades P53 is under the control of p53 in a regulatory feedback loop (Fig. |
[ |
PML (Promyelocytic Leukemia) | ↓ −2.50 (p = 0.023) 24 h | NS | Nuclear protein involved in cell cycle progression, DNA damage response, and apoptosis, i.e. key regulator in the p53 pathway. PML-deficient mice exhibit apoptotic defects. |
[ |
BAX (BCL2 Associated X, Apoptosis Regulator) | ↓−2.22 ( | NS | Major promoter of apoptosis is regulated by p53, it has been involved in tumorigenesis by interfering with cell death. |
[ |
P53 (Tumor Protein P53 or TP53 as in Fig. | NS | ↓ −1.92 ( | Tumor suppressor, a key transcription factor inhibiting cancer development, being inactivated in most tumors. It responds to cell stress by activating genes responsible for DNA repair, cell cycle arrest, anti-angiogenesis, apoptosis and autophagy |
[ |
E2F1 (E2F Transcription Factor 1) | NS | ↑ 2.75 ( | Transcription factor that regulates cell cycle progression, involved in either oncogenesis or tumor suppression depending on cellular signals. E2F1 over expression associated with oncogenic transformation in rodent embryonic fibroblasts and tumorigenesis. |
[ |
**Fold change and P value, upregulation (↑), downregulation (↓), NS, non-significant. The exposure time of cells co-cultured with indicated schistosome eggs (2 h and/or 24 h) for which the specific gene expression dysregulation was detected is indicated after the Fold change.
Figure 6Upstream regulatory analysis (URA) of differentially expressed genes (DEGs) predicted the estrogen receptor and beta-estradiol (P < 0.05) to be inhibited in HCV29 cells co-culture for 24 h with S. haematobium eggs. Panel A. Significantly upregulated genes are shown in red. These genes, negatively regulated (T-symbol) by the estrogen receptor, were found to be upregulated in HCV29 cells co-cultured with S. haematobium eggs for 24 hours; red dashed lines indicate that these genes were activated. Therefore, the URA analysis significantly predicted the estrogen receptor as an inhibited upstream regulator of this set of genes in this dataset. Panel B. Significantly downregulated genes are shown in green. These genes, positively regulated (arrow) by beta-estradiol, were found to be downregulated in HCV29 cells co-cultured with S. haematobium eggs for 24 hours; blue dashed lines indicate that these genes were inhibited in our dataset. Therefore, the URA analysis significantly predicted beta-estradiol as an inhibited upstream regulator of this set of genes in the dataset.